Khamseh ME - Search Results

1

Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.

Khamseh ME, Malek M, Jahangiri S, Nobarani S, Hekmatdoost A, Salavatizadeh M, Soltanieh S, Chehrehgosha H, Taheri H, Montazeri Z, Attaran F, Ismail-Beigi F, Alaei-Shahmiri F. Khamseh ME, et al. Dig Dis Sci. 2024 Apr;69(4):1430-1443. doi: 10.1007/s10620-024-08309-9. Epub 2024 Mar 4. Dig Dis Sci. 2024. PMID: 38438774

2

Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes.

Salavatizadeh M, Soltanieh S, Poustchi H, Yari Z, Shabanpur M, Mansour A, Khamseh ME, Alaei-Shahmiri F, Hekmatdoost A. Salavatizadeh M, et al. Among authors: khamseh me. Front Nutr. 2022 Nov 3;9:1037851. doi: 10.3389/fnut.2022.1037851. eCollection 2022. Front Nutr. 2022. PMID: 36407541 Free PMC article.

3

The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM).

Soltanieh S, Salavatizadeh M, Poustchi H, Yari Z, Mansour A, Khamseh ME, Malek M, Alaei-Shahmiri F, Hekmatdoost A. Soltanieh S, et al. Among authors: khamseh me. Heliyon. 2023 Feb 23;9(3):e13983. doi: 10.1016/j.heliyon.2023.e13983. eCollection 2023 Mar. Heliyon. 2023. PMID: 36915483 Free PMC article.

4

Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Salavatizadeh M, Soltanieh S, Ataei Kachouei A, Abdollahi Fallahi Z, Kord-Varkaneh H, Poustchi H, Mansour A, Khamseh ME, Alaei-Shahmiri F, Santos HO, Hekmatdoost A. Salavatizadeh M, et al. Among authors: khamseh me. Front Endocrinol (Lausanne). 2023 Aug 22;14:1228072. doi: 10.3389/fendo.2023.1228072. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37674617 Free PMC article.

5

Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial.

Attaran F, Emami S, Sohrabi M, Malek M, Ajdarkosh H, Khoonsari M, Ismail-Beigi F, Khamseh ME. Attaran F, et al. Among authors: khamseh me. BMC Gastroenterol. 2023 Sep 23;23(1):327. doi: 10.1186/s12876-023-02948-4. BMC Gastroenterol. 2023. PMID: 37742004 Free PMC article. Clinical Trial.

6

Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes.

Montazeri Z, Hashemi-Madani N, Iraji H, Sohrabi M, Alaei-Shahmiri F, Emami Z, Babaei MR, Malek M, Khamseh ME. Montazeri Z, et al. Among authors: khamseh me. BMC Endocr Disord. 2023 Sep 25;23(1):202. doi: 10.1186/s12902-023-01460-w. BMC Endocr Disord. 2023. PMID: 37749528 Free PMC article.

7

The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review.

Jahangiri S, Malek M, Kalra S, Khamseh ME. Jahangiri S, et al. Among authors: khamseh me. Diabetes Ther. 2023 Dec;14(12):2015-2030. doi: 10.1007/s13300-023-01481-7. Epub 2023 Oct 14. Diabetes Ther. 2023. PMID: 37837581 Free PMC article. Review.

8

Glucagon-Like Peptide 1 (GLP-1) Receptor Variants and Glycemic Response to Liraglutide: A Pharmacogenetics Study in Iranian People with Type 2 Diabetes Mellitus.

Eghbali M, Alaei-Shahmiri F, Hashemi-Madani N, Emami Z, Mostafavi L, Malek M, Khamseh ME. Eghbali M, et al. Among authors: khamseh me. Adv Ther. 2024 Feb;41(2):826-836. doi: 10.1007/s12325-023-02761-1. Epub 2024 Jan 4. Adv Ther. 2024. PMID: 38172377 Clinical Trial.

9

Appropriateness of Intensive Statin Treatment in People with Type Two Diabetes and Mild Hypercholesterolemia: A Randomized Clinical Trial.

Gorji MT, Alaei-Shahmiri F, Darban Hosseini Amirkhiz G, Sezavar SH, Malek M, Khamseh ME. Gorji MT, et al. Among authors: khamseh me. Arch Iran Med. 2023 Jun 1;26(6):290-299. doi: 10.34172/aim.2023.45. Arch Iran Med. 2023. PMID: 38310429 Free PMC article. Clinical Trial.

10

Attitude and Belief of Healthcare Professionals Towards Effective Obesity Care and Perception of Barriers; An Updated Systematic Review and Meta-analysis.

Khamseh ME, Emami Z, Iranpour A, Mahmoodian R, Amouei E, Tizmaghz A, Moradi Y, Baradaran HR. Khamseh ME, et al. Arch Iran Med. 2023 Sep 1;26(9):529-541. doi: 10.34172/aim.2023.78. Arch Iran Med. 2023. PMID: 38310408 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page